Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/CDKN2A genotype patient
J Eur Acad Dermatol Venereol
.
2016 Oct;30(10):e65-e67.
doi: 10.1111/jdv.13310.
Epub 2015 Sep 2.
Authors
M Böhm
1
,
K Jagirdar
2
,
R A Sturm
2
,
S König
3
,
J Bauer
4
,
D Metze
5
,
T A Luger
5
,
C Weishaupt
5
Affiliations
1
Department of Dermatology, University of Münster, Münster, Germany. bohmm@uni-muenster.de.
2
Dermatology Research Centre, School of Medicine, Translational Research Institute, The University of Queensland, Brisbane, Qld, Australia.
3
Proteomics Unit, Interdisciplinary Center for Clinical Research, University of Münster, Münster, Germany.
4
Department of Dermatology, University of Tübingen, Tübingen, Germany.
5
Department of Dermatology, University of Münster, Münster, Germany.
PMID:
26333485
DOI:
10.1111/jdv.13310
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Adult
Female
Genes, p16*
Genotype
Humans
Melanocortins / administration & dosage*
Melanoma / genetics*
Receptor, Melanocortin, Type 1 / genetics*
Young Adult
Substances
Melanocortins
Receptor, Melanocortin, Type 1